NCT00416624
- Conditions
- Amyloidosis, Anemia, Blood Protein Disorders, +72 more
- Locations
-
- Mayo Clinic Rochester, Minnesota, United States
Clinical trial condition
Lymphoma, Large B-Cell, Diffuse
Explore clinical trials studying Lymphoma, Large B-Cell, Diffuse. Study availability and eligibility vary by location and protocol.
1,249 public trials
217 recruiting studies
Lymphoma, Large B-Cell, Diffuse trial results
Completed
AMG 319 Lymphoid Malignancy FIH
NCT01300026
- Conditions
- Cancer, Chronic Disease, Chronic Lymphocytic Leukemia, +33 more
- Locations
-
- Research Site Hackensack, New Jersey, United States
- Research Site Durham, North Carolina, United States
- Research Site Salt Lake City, Utah, United States
NCT00719563
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +103 more
- Locations
-
- Mayo Clinic Scottsdale Scottsdale, Arizona, United States
- Aurora Presbyterian Hospital Aurora, Colorado, United States
- Boulder Community Hospital Boulder, Colorado, United States
- Penrose Cancer Center at Penrose Hospital Colorado Springs, Colorado, United States
NCT00005089
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +16 more
- Locations
-
- MBCCOP - Gulf Coast Mobile, Alabama, United States
- CCOP - Greater Phoenix Phoenix, Arizona, United States
- Veterans Affairs Medical Center - Phoenix (Hayden) Phoenix, Arizona, United States
- Veterans Affairs Medical Center - Tucson Tucson, Arizona, United States
NCT00931918
- Conditions
- Acromesomelic dysplasia, Maroteaux type, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
- Tower Cancer Research Foundation Beverly Hills, California, United States
- Fountain Valley Regional Hospital Fountain Valley, California, United States
- St. Jude Heritage Healthcare Fullerton, California, United States
- Moores Cancer Center- UCSD La Jolla, California, United States
NCT01741792
- Conditions
- Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Universitätsmedizin Göttingen, Germany
- Universitätsklinikum des Saarlandes Homburg, Germany
- Universitätsklinikum Schleswig Holstein Kiel, Germany
- Klinikum der Johannes-Gutenberg Universität Mainz, Germany
NCT00053053
- Conditions
- Body Weight, Body Weight Changes, Burkitt Lymphoma, +44 more
- Locations
-
- Comprehensive Cancer Center at University of Alabama at Birmingham Birmingham, Alabama, United States
- Comprehensive Cancer Institute Huntsville, Alabama, United States
- MBCCOP - Gulf Coast Mobile, Alabama, United States
- Montgomery Cancer Center Montgomery, Alabama, United States
Completed
Combination Chemotherapy Plus Rituximab in Treating Patients With Relapsed Non-Hodgkin's Lymphoma
NCT00005601
- Conditions
- Burkitt Lymphoma, Chronic Disease, DNA Virus Infections, +29 more
- Locations
-
- CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States
- Mayo Clinic Jacksonville, Florida, United States
- CCOP - Illinois Oncology Research Association Peoria, Illinois, United States
- CCOP - Cedar Rapids Oncology Project Cedar Rapids, Iowa, United States
NCT01421667
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- City of Hope Duarte, California, United States
- PMK Medical Group Inc., DBA Ventura County Hematology Oncology Specialists Oxnard, California, United States
- Stanford Cancer Center Stanford, California, United States
NCT00607854
- Conditions
- Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- Service d'hématologie - CHU de Besançon Besançon, France
- Service des maladies du sang - Hôpital Haut-Lévêque - avenue de magellan Bordeaux - Pessac, France
- Service d'hématologie - CHU Hôtel Dieu Clermont-Ferrand Clermont-Ferrand, France
- Service de médecine nucléaire - Centre de Lutte contre le Cancer de la Région Auvergne Jean Perrin Clermont-Ferrand, France